Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

New compounds may help treat heart disease by activating specific potassium channels.

ART for HIV/AIDS can cause side effects but is crucial for managing the infection.

Finasteride and dutasteride do not significantly change beard thickness in men.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

New compounds may help treat prostate issues without affecting androgen receptors.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Artocarpus heterophyllus seed extract may help treat prostate inflammation without side effects.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Upadacitinib improved multiple immune-related conditions in one patient.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Antiretrovirals can affect finasteride's effectiveness, so dose adjustments may be needed for men on HIV treatment.